Get started
Profound Medical Corp.Profound Medical Corp.Profound Medical Corp.

Profound Medical Corp.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

PROF chart


Full chart

PROF upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪180.62 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.21USD
Net income (FY)
‪−29.09 M‬USD
Revenue (FY)
‪7.33 M‬USD
Shares float
‪20.93 M‬
Beta (1Y)
1.63

Employees


Employees (FY)
131
Revenue / Employee (1Y)
‪55.96 K‬USD
Net income / Employee (1Y)
‪−222.08 K‬USD

About PROFOUND MED CORP


Sector
Health Technology
Industry
Medical Specialties
CEO
Arun S. Menawat
Website
profoundmedical.com
Headquarters
Mississauga
Founded
2008
FIGI
BBG00CXJY8L7
Profound Medical Corp. engages in developing, manufacturing, and marketing of therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. Its platforms offer clinicians and patients incision-free alternatives to current standards of care, which could include traditional surgery or radiation therapy. Its products include TULSA-PRO and Sonalleve. The company was founded in 2008 and is headquartered in Mississauga, Canada.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas



See all ideas 

PROF news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of PROF is 8.20 USD — it has increased by 11.56% in the past 24 hours. Watch Profound Medical Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Profound Medical Corp. stocks are traded under the ticker PROF.
PROF stock has risen by 11.56% compared to the previous week, the month change is a 3.80% rise, over the last year Profound Medical Corp. has showed a −13.68% decrease.
We've gathered analysts' opinions on Profound Medical Corp. future price: according to them, PROF price has a max estimate of 19.00 USD and a min estimate of 12.00 USD. Watch PROF chart and read a more detailed Profound Medical Corp. stock forecast: see what analysts think of Profound Medical Corp. and suggest that you do with its stocks.
PROF reached its all-time high on Feb 8, 2021 with the price of 28.97 USD, and its all-time low was 0.03 USD and was reached on Jul 19, 2017. View more price dynamics on PROF chart.
See other stocks reaching their highest and lowest prices.
PROF stock is 22.48% volatile and has beta coefficient of 1.63. Track Profound Medical Corp. stock price on the chart and check out the list of the most volatile stocks — is Profound Medical Corp. there?
Today Profound Medical Corp. has the market capitalization of ‪180.62 M‬, it has increased by 3.71% over the last week.
Yes, you can track Profound Medical Corp. financials in yearly and quarterly reports right on TradingView.
Profound Medical Corp. is going to release the next earnings report on Nov 7, 2024. Keep track of upcoming events with our Earnings Calendar.
PROF earnings for the last quarter are −0.28 USD per share, whereas the estimation was −0.28 USD resulting in a 0.59% surprise. The estimated earnings for the next quarter are −0.30 USD per share. See more details about Profound Medical Corp. earnings.
Profound Medical Corp. revenue for the last quarter amounts to ‪2.23 M‬ USD, despite the estimated figure of ‪2.64 M‬ USD. In the next quarter, revenue is expected to reach ‪3.00 M‬ USD.
PROF net income for the last quarter is ‪−6.92 M‬ USD, while the quarter before that showed ‪−6.17 M‬ USD of net income which accounts for −12.09% change. Track more Profound Medical Corp. financial stats to get the full picture.
No, PROF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 5, 2024, the company has 131.00 employees. See our rating of the largest employees — is Profound Medical Corp. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Profound Medical Corp. EBITDA is ‪−29.21 M‬ USD, and current EBITDA margin is −381.58%. See more stats in Profound Medical Corp. financial statements.
Like other stocks, PROF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Profound Medical Corp. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Profound Medical Corp. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Profound Medical Corp. stock shows the sell signal. See more of Profound Medical Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.